References
1. Jishu Wei, Shibo Lin, Cong Wang, Junli Wu, Zhuyin Qian, Cuncai Dai,
et al. Glucagonoma syndrome: A case report. Oncol Lett. 2015;10
(2):1113-6
2. Teixeira RC, Nico MMS, Ghideti AC. Necrolytic migratory erythema
associated with glucagonoma: a report of 2 cases. Clinics.
2008;63(2):267‑70.
3. Beek Á PV, Haas ERMD, Vloten WAV, Lips CJM, Roijers JFM, Dijk MRC.
The glucagonoma syndrome and necrolytic migratory erythema: a clinical
review. Eur J Endocrinol. 2004;151:531-7.
4. Tolliver S, Graham J, Kaffenberger BH. A review of cutaneous
manifestations within glucagonoma syndrome: necrolytic migratory
erythema. Int J Dermatol. 2018;57(6):642‑5.
5. Khoshnia M, Norouzi A, Hosseininejad S-M, Hosseininejad F-S.
Glucagonoma Neuroendocrine Tumor with the Clue of Necrolytic Migratory
Erythematous Rash: A Case Report. 2018;2(1):2292-5.
6. Wu S, Bai J, Xu J, Ma Q, Wu Z. Necrolytic migratory erythema as the
first manifestation of pancreatic neuroendocrine tumor. World J Surg
Oncol. 2014;12(1):220.
7. Halvorson SAC, Gilbert E, Hopkins RS, Liu H, Lopez C, Chu M, et al.
Putting the Pieces Together: Necrolytic Migratory Erythema and the
Glucagonoma Syndrome. J Gen Intern Med. 2013;28(11):1525‑9.
8. Afsharfard A, Atqiaee K, Lotfollahzadeh S, Alborzi M, Derakhshanfar
A. Necrolytic Migratory Erythema as the First Manifestation of
Glucagonoma. Case Rep Surg.2012.
9. Han X, Wang D, Kuang T, Rong Y, Lou W. Glucagonoma syndrome: report
of one case. Transl Gastro enterol Hepatol. 2016;1.
10. Cruz-Bautista I, Lerman I, Perez-Enriquez B, Padilla LS, Torres CL,
Lopez A, et al. Diagnostic challenge of glucagonoma: case report and
literature review. Endocr Pract. 2006;12(4):422‑6.
11. Sheng Fang, Shuang Li, Tao Cai. Glucagonoma syndrome: a case report
with focus on skin disorders. Onco Targets Ther. 2014;7:1449–53.
12. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. The
Glucagonoma Syndrome Clinical and Pathologic Features in 21 Patients:
Medicine (Baltimore).1996;75(2):53‑63.
13. el Darouty M, Abu el Ela M. Necrolytic migratory erythema without
glucagonoma in patients with liver disease. J Am Acad Dermatol.
1996;34(6):1092‑3.
14. Dinc B, Sahin C. Metastatic glucagonoma. Eurasian J Med.
2009;41(1):70.
15. Feldmann R, Wahl S, Steiner A. Normoglycemic glucagonoma syndrome
associated with necrolytic migratory erythema. J Eur Acad Dermatol
Venereol JEADV. 2018;32(8):e306‑7.
16. Tremblay C, Marcil I. Necrolytic Migratory Erythema: A Forgotten
Paraneoplastic Condition. J Cutan Med Surg. 2017;21(6):559-61.
17. Cardoso D, Cardoso A, Filho FC. Pancreatic glucagonoma associated
with necrolytic migratory erythema: case report and clinical review. Eur
J Cancer. 2017;72:S151.